Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
NCT02888496
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Polymyalgia Rheumatica
Interventions
DRUG:
tocilizumab
Sponsor
University Hospital, Brest